University of Cambridge and AstraZeneca Offer Non-clinical PhD Studentship on Improved 2A Peptides in Cambridge, England, United Kingdom

The University of Cambridge Department of Pathology, with AstraZeneca Discovery Centre Cambridge, offers a 4-year AstraZeneca-funded non-clinical PhD studentship in Cambridge, England, starting 1 October 2027, on improved 2A peptides for co-expression in gene therapy and viral vectors.

Job Details

Company: University of Cambridge Department of Pathology, with AstraZeneca Discovery Centre Cambridge

Position: AstraZeneca-funded Non-clinical PhD Studentship: Improved 2A Peptides 2026

Location: Cambridge, England, United Kingdom

Duration: 4-year studentship

Start Date: 1 October 2027

Job Description

The University of Cambridge Department of Pathology, with AstraZeneca Discovery Centre Cambridge, offers a 4-year AstraZeneca-funded non-clinical PhD studentship (start 1 October 2027) on improved 2A peptides for co-expression in gene therapy and viral vectors.

The project centres on molecular biology with opportunities across collaborative AZ–Cambridge supervision.

How to Apply

Apply through the University of Cambridge official jobs listing for PhD in Pathology.

CLICK HERE FOR THE ORIGINAL NOTIFICATION / APPLY ONLINE

Apply through the University of Cambridge official jobs listing for PhD in Pathology.